{"id":"NCT00309751","sponsor":"Kowa Research Europe","briefTitle":"Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia","officialTitle":"Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2007-06","completion":"2007-06","firstPosted":"2006-04-03","resultsPosted":"2010-01-18","lastUpdate":"2010-02-23"},"enrollment":418,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type II Diabetes Mellitus","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"Pitavastatin","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor"]}],"arms":[{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL"},{"label":"Atorvastatin 20 mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.","primaryOutcome":{"measure":"Percent Change From Baseline Low Density Lipoprotein Cholesterol (LDL-C)","timeFrame":"12 weeks","effectByArm":[{"arm":"Pitavastatin 4 mg QD","deltaMin":-40.78,"sd":19.599},{"arm":"Atorvastatin 20 mg QD","deltaMin":-43.25,"sd":16.378}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":35,"countries":["Denmark","Germany","India","Netherlands","Poland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4},"commonTop":["Nasopharyngitis","Diarrhea","Myalgia","Hypertension"]}}